Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 13.06% |
| 3 | Consumer Discretionary | 12.03% |
| 4 | Consumer Staples | 11.17% |
| 5 | Industrials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Madison Square Garden
MSGS
$9.47B
| $57.7M | 0.14% |
1,405,505
-171,044
| -11% | -$6.96M |
|
|
SRCL
152
DELISTED
Stericycle Inc
SRCL
| $57.4M | 0.14% |
494,420
+129,800
| +36% | +$15.1M |
|
153
TE Connectivity
TEL
$63.3B
| $56.7M | 0.14% |
1,029,500
+241,500
| +31% | +$12.7M |
|
|
ETP
154
DELISTED
Energy Transfer Partners L.p.
ETP
| $55.1M | 0.13% |
963,113
+537,834
| +126% | +$28.5M |
|
|
MGAM
155
DELISTED
MULTIMEDIA GAMES HOLDING COMPANY INC COM STK (TX)
MGAM
| $55.1M | 0.13% |
1,756,500
+120,300
| +7% | +$3.74M |
|
156
Kroger
KR
$34.5B
| $55M | 0.13% |
2,784,600
-1,924,400
| -41% | -$39.8M |
|
|
BHI
157
DELISTED
Baker Hughes
BHI
| $54.5M | 0.13% |
986,840
+301,400
| +44% | +$16.5M |
|
|
LSI
158
DELISTED
Life Storage, Inc.
LSI
| $54.5M | 0.13% |
1,254,150
+111,900
| +10% | +$5.27M |
|
|
SEE
159
DELISTED
Sealed Air
SEE
| $54.4M | 0.13% |
1,596,900
-252,400
| -14% | -$7.69M |
|
160
Ericsson
ERIC
$33B
| $53.7M | 0.13% |
4,390,400
+2,124,800
| +94% | +$26.4M |
|
|
BYI
161
DELISTED
BALLY TECHNOLOGIES, INC.
BYI
| $53.7M | 0.13% |
684,700
+250,300
| +58% | +$18.2M |
|
162
Expedia Group
EXPE
$38.5B
| $53.5M | 0.13% |
+767,934
| New | +$45.2M |
|
|
CTRX
163
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $53.2M | 0.13% |
1,121,470
+191,500
| +21% | +$9.03M |
|
164
Novartis
NVS
$294B
| $53M | 0.13% |
735,777
+262,370
| +55% | +$18.2M |
|
|
GAP
165
The Gap Inc
GAP
$7.55B
| $52.5M | 0.13% |
1,343,700
-748,300
| -36% | -$29.3M |
|
166
Factset
FDS
$10.1B
| $52.4M | 0.13% |
482,750
+53,550
| +12% | +$5.94M |
|
167
Boston Scientific
BSX
$74.2B
| $52.4M | 0.13% |
4,358,620
-444,885
| -9% | -$5.26M |
|
|
MJN
168
DELISTED
Mead Johnson Nutrition Company
MJN
| $52.2M | 0.12% |
622,700
-415,000
| -40% | -$33.8M |
|
169
Oil States International
OIS
$532M
| $52.1M | 0.12% |
897,050
+29,400
| +3% | +$1.76M |
|
|
XLNX
170
DELISTED
Xilinx Inc
XLNX
| $52M | 0.12% |
1,133,205
+442,200
| +64% | +$19.9M |
|
|
CIT
171
DELISTED
CIT Group Inc.
CIT
| $52M | 0.12% |
997,900
+14,700
| +1% | +$730K |
|
|
PLKI
172
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
| $52M | 0.12% |
1,350,644
+192,400
| +17% | +$8.1M |
|
173
Equifax
EFX
$21.4B
| $51.9M | 0.12% |
751,295
+42,500
| +6% | +$2.76M |
|
174
Microchip Technology
MCHP
$44B
| $51.7M | 0.12% |
2,311,594
+170,800
| +8% | +$3.58M |
|
175
Macy's
M
$6.45B
| $51.6M | 0.12% |
966,164
+521,200
| +117% | +$25.3M |
|
Similar funds
Jim Simons's Q4 2013 Portfolio in Review
As of Q4 2013, Jim Simons held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Pfizer worth $230M.
- Jim Simons's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Jim Simons added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Jim Simons's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Jim Simons fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Jim Simons's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Jim Simons opened 498 new positions and closed 464 in Q4 2013.
- Jim Simons's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.